Samuraciclib

DB16061InvestigationalSmall molecule

Samuraciclib is under investigation in clinical trial NCT03363893 (Modular Study to Evaluate CT7001 Alone in Cancer Patients With Advanced Malignancies).

Chemical structure of Samuraciclib
Formula / weight
C22H30N6O · 394.523 g/mol (avg)
Code names
CT-7001 · ICEC-0942

Resolves to

Compound
UNII46D4HS9ODACAS1805833-75-3ChEMBLCHEMBL4297488
Structure
InChIKeyYCVGLKWJKIKVBI-MJGOQNOKSA-NSMILESCC(C)C1=C2N=C(NC[C@H]3CCNC[C@@H]3O)C=C(NCC3=CC=CC=C3)N2N=C1
Targets
P50613CDK7

What you can answer from here — as of June 13, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
7Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Samuraciclib, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In